A randomized, controlled study of amiodarone for prevention of atrial fibrillation after transthoracic esophagectomy

Journal of Thoracic and Cardiovascular Surgery

Volumn 140, Issue 1, 2010, Pages 45-51

  Tisdale, James E ^a,b   Wroblewski, Heather A ^a   Wall, Donna S ^b   Rieger, Karen M ^b   Hammoud, Zane T ^b   Young, Jerry V ^b   Kesler, Kenneth A ^b  

^a PURDUE UNIVERSITY   (United States)

^b INDIANA UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMIODARONE; ANGIOTENSIN RECEPTOR ANTAGONIST; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM CHANNEL BLOCKING AGENT; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; HYPERTENSIVE AGENT; NONSTEROID ANTIINFLAMMATORY AGENT;

ADULT; ADULT RESPIRATORY DISTRESS SYNDROME; ANASTOMOSIS LEAKAGE; ARTICLE; ATELECTASIS; BRADYCARDIA; CLINICAL TRIAL; COMORBIDITY; CONTINUOUS INFUSION; CONTROL GROUP; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DEMOGRAPHY; DRUG BLOOD LEVEL; DRUG EFFICACY; DRUG SAFETY; DRUG WITHDRAWAL; ELECTROCARDIOGRAPHY; ESOPHAGUS CANCER; ESOPHAGUS RESECTION; FEMALE; HEART ATRIUM FIBRILLATION; HEART VENTRICLE TACHYCARDIA; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HOSPITALIZATION; HUMAN; HYPOTENSION; INTENSIVE CARE UNIT; LIVER TOXICITY; LUNG FIBROSIS; MAJOR CLINICAL STUDY; MALE; PERICARDIAL EFFUSION; PNEUMONIA; POSTOPERATIVE PERIOD; PREOPERATIVE EVALUATION; PRIORITY JOURNAL; PROPHYLAXIS; PROSPECTIVE STUDY; QT PROLONGATION; RANDOMIZED CONTROLLED TRIAL; RISK FACTOR; RISK REDUCTION; THYROID DISEASE; TRANSTHORACIC ESOPHAGECTOMY; TREATMENT DURATION;

AGED; AMIODARONE; ANTI-ARRHYTHMIA AGENTS; ATRIAL FIBRILLATION; CHI-SQUARE DISTRIBUTION; DRUG ADMINISTRATION SCHEDULE; ESOPHAGECTOMY; FEMALE; HUMANS; INCIDENCE; INDIANA; INFUSIONS, INTRAVENOUS; INTENSIVE CARE; KAPLAN-MEIERS ESTIMATE; LENGTH OF STAY; MALE; MIDDLE AGED; PROSPECTIVE STUDIES; TIME FACTORS; TREATMENT OUTCOME;

EID: 77953479808     PISSN: 00225223     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jtcvs.2010.01.026     Document Type: Article

References (25)

1. Konno O., Tezuka T., Muto A., Hoshino Y., Kogure M., Koyama S., et al. [Postoperative arrhythmia after operation of esophageal cancer]. Nippon Kyobu Geka Gakkai Zasshi 41 (1993) 45-51 Japanese
2. Amar D., Burt M.E., Bains M.S., and Leung D.H. Symptomatic tachydysrhythmias after esophagectomy: incidence and outcome measures. Ann Thorac Surg 61 (1996) 1506-1509
3. Murthy S.C., Law S., Whooley B.P., Alexandrou A., Chu K.-M., and Wong J. Atrial fibrillation after esophagectomy is a marker for postoperative morbidity and mortality. J Thorac Cardiovasc Surg 126 (2003) 1162-1167
4. Vaporciyan A.A., Correa A.M., Rice D.C., Roth J.A., Smythe W.R., Swisher S.G., et al. Risk factors associated with atrial fibrillation after noncardiac thoracic surgery: analysis of 2588 patients. J Thorac Cardiovasc Surg 127 (2004) 779-786
5. Stippel D.L., Taylan C., Schröder W., Beckurts K.T.E., and Hölscher A.H. Supraventricular tachyarrhythmia as early indicator of a complicated course after esophagectomy. Dis Esophagus 18 (2005) 267-273
6. Zimetbaum P. Amiodarone for atrial fibrillation. N Engl J Med 356 (2007) 935-941
7. Daoud E.G., Strickberger S.A., Man K.C., Goyal R., Deeb G.M., Bolling S.F., et al. Preoperative amiodarone as prophylaxis against atrial fibrillation after heart surgery. N Engl J Med 337 (1997) 1785-1791
8. Guarnieri T., Nolan S., Gottlieb S.O., Dudek A., and Lowry D.R. Intravenous amiodarone for the prevention of atrial fibrillation after open heart surgery: the Amiodarone Reduction in Coronary Heart (ARCH) trial. J Am Coll Cardiol 34 (1999) 343-347
9. Giri S., White C.M., Dunn A.B., Felton K., Freeman-Bosco L., Reddy P., et al. Oral amiodarone for prevention of atrial fibrillation after open heart surgery, the Atrial Fibrillation Suppression Trial (AFIST): a randomised placebo-controlled trial. Lancet 357 (2001) 830-836
10. Mitchell L.B., Exner D.V., Wyse D.G., Connolly C.J., Prystai G.D., Bayes A.J., et al. Prophylactic Oral Amiodarone for the Prevention of Arrhythmias that Begin Early After Revascularization, Valve Replacement, or Repair: PAPABEAR: a randomized controlled trial. JAMA 294 (2005) 3093-3100
11. Lanza L.A., Visbal A.I., DeValeria P.A., Zinsmeister A.R., Diehl N.N., and Trastek V.F. Low-dose oral amiodarone prophylaxis reduces atrial fibrillation after pulmonary resection. Ann Thorac Surg 75 (2003) 223-230
12. Tisdale J.E., Wroblewski H.A., Wall D.S., Rieger K.M., Hammoud Z.T., Young J.V., et al. A randomized trial evaluating amiodarone for prevention of atrial fibrillation following pulmonary resection. Ann Thorac Surg 88 (2009) 886-895
13. Fuster V., Rydén L.E., Cannom D.S., Crijns H.J., Curtis A.B., Ellenbogen K.A., et al. ACC/AHA/ESC 2006 guidelines for the management of patients with atrial fibrillation-executive summary: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines and the European Society of Cardiology Committee for Practice Guidelines (Writing Committee to Revise the 2001 Guidelines for the Management of Patients With Atrial Fibrillation). Circulation 114 (2006) 700-752
14. Juenke J.M., Brown P.I., McMillin G.A., and Urry F.M. A rapid procedure for the monitoring of amiodarone and desethylamiodarone by HPLC-UV detection. J Anal Toxicol 28 (2004) 63-66
15. Lévy S., Camm A.J., Saksena S., Aliot E., Breithardt G., Crijns H.J., et al. International consensus on nomenclature and classification of atrial fibrillation: a collaborative project of the Working Group on Arrhythmias and the Working Group on Cardiac Pacing of the European Society of Cardiology and the North American Society of Pacing and Electrophysiology. J Cardiovasc Electrophysiol 14 (2003) 443-445
16. Kalman J.M., Munawar M., Howes L.G., Louis W.J., Buxton B.F., Gutteridge G., et al. Atrial fibrillation after coronary artery bypass grafting is associated with sympathetic activation. Ann Thorac Surg 60 (1995) 1709-1715
17. Guler N., Ozkara C., Dulger H., Kutay V., Sahin M., Erbilen E., et al. Do cardiac neuropeptides play a role in the occurrence of atrial fibrillation after coronary bypass surgery?. Ann Thorac Surg 83 (2007) 532-537
18. Ucar H.I., Tok M., Atalar E., Dogan O.F., Oc M., Farsak B., et al. Predictive significance of plasma levels of interleukin-6 and high-sensitivity C-reactive protein in atrial fibrillation after coronary artery bypass surgery. Heart Surg Forum 10 (2007) E131-E135
19. Amar D., Roistacher N., Burt M., Reinsel R.A., Ginsberg R.J., and Wilson R.S. Clinical and echocardiographic correlates of symptomatic tachydysrhythmias after noncardiac thoracic surgery. Chest 108 (1995) 349-354
20. Amar D., Goenka A., Zhang H., Park B., and Thaler H.T. Leukocytosis and increased risk of atrial fibrillation after general thoracic surgery. Ann Thorac Surg 82 (2006) 1057-1061
21. Ma J.-Y., Wang Y., Zhao Y.-F., Wu Z., Liu L.-X., Kou Y.-L., et al. Atrial fibrillation after surgery for esophageal carcinoma; clinical and prognostic significance. World J Gastroenterol 12 (2006) 449-452
22. Bayliff C.D., Massel D.R., Inculet R.I., Malthaner R.A., Quinton S.D., Powell F.S., et al. Propranolol for the prevention of postoperative arrhythmias in general thoracic surgery. Ann Thorac Surg 67 (1999) 182-186
23. Tisdale J.E., Wroblewski H.A., Hammoud Z.T., Rieger K.M., Young J.V., Wall D.S., et al. Prospective evaluation of serum amiodarone concentrations when administered via a nasogastric tube into the stomach conduit after transthoracic esophagectomy. Clin Ther 29 (2007) 226-234
24. Kotake T., Takada M., Goto T., Komamura K., Kamakura S., and Morishita H. Serum amiodarone and desethylamiodarone concentrations following nasogastric versus oral administration. J Clin Pharm Ther 31 (2006) 237-243
25. Hahm T.-S., Lee J.-J., Yang M.-K., and Kim J.-A. Risk factors for an intraoperative arrhythmia during esophagectomy. Yonsei Med J 48 (2007) 474-479